PAC-1 Trial in Humans with Brain Cancer Extended

PAC-1 Trial in Humans with Brain Cancer Extended

Timothy Fan and Paul Hergenrother A drug that spurs cancer cells to self-destruct has been cleared for use in a clinical trial of patients with anaplastic astrocytoma, a rare malignant brain tumor, and glioblastoma multiforme, an aggressive late-stage cancer of the...